Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Arnout G. Schepers,*
Hugo J. Snippert,*,
Daniel E. Stange,
Maaike van den Born,
Johan H. van Es,
Marc van de Wetering,
Hans Clevers
Abstract:
The concept that tumors are maintained by dedicated stem cells, the so-called cancer stem cell hypothesis, has attracted great interest but remains controversial. Studying mouse models, we provide direct, functional evidence for the presence of stem cell activity within primary intestinal adenomas, a precursor to intestinal cancer. By "lineage retracing" using the multicolor Cre-reporter R26R-Confetti, we demonstrate that the crypt stem cell marker Lgr5 (leucine-rich repeat–containing heterotrimeric guanine nucleotide–binding protein–coupled receptor 5) also marks a subpopulation of adenoma cells that fuel the growth of established intestinal adenomas. These Lgr5+ cells, which represent about 5 to 10% of the cells in the adenomas, generate additional Lgr5+ cells as well as all other adenoma cell types. The Lgr5+ cells are intermingled with Paneth cells near the adenoma base, a pattern reminiscent of the architecture of the normal crypt niche.
Hubrecht Institute, Koninklijke Nederlandse Akademie van Wetenschappen, and University Medical Center Utrecht, Uppsalalaan 8, 3584 CT Utrecht, Netherlands.
* These authors contributed equally to this work.
Present address: Molecular Cancer Research, Centre of Biomedical Genetics and Cancer Genomics Centre, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, Netherlands.
To whom correspondence should be addressed. E-mail: h.clevers{at}hubrecht.eu
The editors suggest the following Related Resources on Science sites:
In Science Signaling
EDITORS' CHOICE
Paula A. Kiberstis (14 August 2012) Sci. Signal.5 (237), ec212.
[DOI: 10.1126/scisignal.2003499] |Abstract »
T. Lau, E. Chan, M. Callow, J. Waaler, J. Boggs, R. A. Blake, S. Magnuson, A. Sambrone, M. Schutten, R. Firestein, et al. (2013)
Cancer Res.
73, 3132-3144
|Abstract »|Full Text »|PDF »
Caught in the act: revealing the metastatic process by live imaging.
LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.
M. R. A. Al-Kharusi, H. J. M. Smartt, A. Greenhough, T. J. Collard, E. D. Emery, A. C. Williams, and C. Paraskeva (2013)
Carcinogenesis
34, 1150-1157
|Abstract »|Full Text »|PDF »
Constitutive Internalization of the Leucine-rich G Protein-coupled Receptor-5 (LGR5) to the Trans-Golgi Network.
J. C. Snyder, L. K. Rochelle, H. K. Lyerly, M. G. Caron, and L. S. Barak (2013)
J. Biol. Chem.
288, 10286-10297
|Abstract »|Full Text »|PDF »
Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation.
F. C. Lourenco, J. Munro, J. Brown, J. Cordero, R. Stefanatos, K. Strathdee, C. Orange, S. M. Feller, O. J. Sansom, M. Vidal, et al. (2013)
Gut
|Abstract »|Full Text »
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology.
S. L. Liauw, P. P. Connell, and R. R. Weichselbaum (2013)
Science Translational Medicine
5, 173sr2
|Full Text »|PDF »
Single-Molecule Genomic Data Delineate Patient-Specific Tumor Profiles and Cancer Stem Cell Organization.
A. Sottoriva, I. Spiteri, D. Shibata, C. Curtis, and S. Tavare (2013)
Cancer Res.
73, 41-49
|Abstract »|Full Text »|PDF »
Obesity, Energy Balance, and Cancer: New Opportunities for Prevention.
S. D. Hursting, J. DiGiovanni, A. J. Dannenberg, M. Azrad, D. LeRoith, W. Demark-Wahnefried, M. Kakarala, A. Brodie, and N. A. Berger (2012)
Cancer Prevention Research
5, 1260-1272
|Abstract »|Full Text »|PDF »